Swati Patel
University of Colorado, Rocky Mountain Regional VA
Appearances
DateMay 6, 2023SOCIETY: ASGEPresenter
University of Colorado, Rocky Mountain Regional VA
AGA GI Cancer Risk Assessment and Strategies for Management of Individuals at High Risk: What's New?
DateMay 6, 2023SOCIETY: AGAModerators
University of Colorado, Rocky Mountain Regional VAOhio State University Wexner Medical Center
DateMay 20, 2024SOCIETY: AGA Multiple areas of colon cancer screening are evolving rapidly. These include effectiveness, AI, positioning of noninvasive testing and optimal management of sessile serrated lesions. This session will incorporate international experts to address these questions…Moderators
Kaiser PermanenteUniversity of Colorado, Rocky Mountain Regional VA
DateMay 19, 2024LIVE STREAM SESSION Understanding the environmental impact of endoscopy practice and review ways of mitigating waste and improving climate sustainabilityModerators
University of Colorado, Rocky Mountain Regional VACleveland Clinic- DateMay 19, 2024
Presenter
University of Colorado, Rocky Mountain Regional VA - DateMay 19, 2024
Presenters
Cedars-Sinai Medical CenterAdventHealth Medical Group at Altamonte SpringsUniversity of Colorado, Rocky Mountain Regional VAUniversity of California, Irvine 
DateMay 18, 2024MODELING THE TUMOR MICROENVIRONMENT OF EARLY AND LATE ONSET COLORECTAL CANCER USING PATIENT-DERIVED ORGANOIDSModerators
University of Colorado, Rocky Mountain Regional VAThe University of Texas Health Science Center at Houston School of Public HealthSpeakers
Sunnybrook Health Sciences Centre- DateMay 20, 2024Background & Aims: Inflammatory bowel disease (IBD) and Lynch syndrome (LS) are both risk factors for colorectal cancer (CRC), however it is unclear if those with LS+IBD have compounded cancer risk or if they would benefit from more intensive surveillance…
Presenter
Speakers
University of Colorado Anschutz Medical CampusUniversity of Colorado, Rocky Mountain Regional VA - DateMay 20, 2024BACKGROUND & AIM: Advanced adenomas (AAs) [≥1cm, villous, or high-grade dysplasia (HGD)] are precursors to colorectal cancer (CRC) and although guidelines support multi-gene panel testing (MGPT) in those with CRC, it is unclear if MGPT should be performed in individuals with CRC precursors…
Presenter
University of Colorado, Rocky Mountain Regional VASpeakers
University of Kansas Medical Center/VAMCUniversity of California San DiegoUniversity of Chicago 
DateMay 6, 2025SOCIETY: AGAModerators
University of Colorado, Rocky Mountain Regional VAOhio State University Wexner Medical Center
